A notably higher proportion of obesity (BMI 25.0–29.9: 30.51%, BMI 30.0–39.9:13.21%) was observed within the GLP‐1 RAs group, compared with other treatment groups. The gene discussed is GLP1R; the disease is obesity due to melanocortin 4 receptor deficiency.